Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cancer Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Cancer Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Cancer Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Cancer Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Cancer Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Cancer Genetics Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Cancer Genetics Acquires Assets of Response Genetics for USD14 Million 11
Partnerships 13
PierianDx Enters into Agreement with Cancer Genetics 13
Cancer Genetics Enters into Partnership with Mendel Health 14
Cancer Genetics Enters into Agreement with Lantern Pharma 15
Cancer Genetics Partners with ApoCell for ApoStream 16
Cancer Genetics Partners with H3 Biomedicine 17
Cancer Genetics Enters into Distribution Agreement with Sayre Therapeutics 18
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 19
Cancer Genetics Italia Enters Into Distribution Agreement With Nikon Instruments 20
Merger 21
NovellusDx to Merge with Cancer Genetics 21
Equity Offering 23
Cancer Genetics Prices USD7 Million in Private Placement of Units 23
Cancer Genetics Raises USD3 Million in First Tranche of Private Placement of Shares 24
Cancer Genetics to Raise USD5.5 Million in Private Placement of Shares and Warrants 25
Cancer Genetics Raises USD5 Million in Private Placement of Shares and Warrants 26
Cancer Genetics Raises USD12 Million in Public Offering of Shares 27
Cancer Genetics Completes Public Offering Of Shares For US$46 Million 29
Cancer Genetic Announces Public Offering Of Common Stock For Up To US$50 Million 31
Cancer Genetics Completes Underwriters’ Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For US$16 Million 32
Cancer Genetics Completes IPO For US$7 Million 33
Debt Offering 35
Cancer Genetics Raises USD2.6 Million in Private Placement of 10% Notes Due 2019 35
Acquisition 36
ReproCELL Acquires BioServe Biotech from Cancer Genetics for USD1.9 Million 36
Cancer Genetics Inc – Key Competitors 37
Cancer Genetics Inc – Key Employees 38
Cancer Genetics Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Joint Venture 40
Recent Developments 41
Strategy And Business Planning 41
Sep 20, 2018: Cancer Genetics and NovellusDx agree to merge 41
Apr 03, 2017: Cancer Genetics and Mendel Announce Strategic Partnership Enabling Artificial Intelligence in Precision Medicine to Drive Personalized Treatment and Accelerate Clinical Trial Matching for Cancer Care 42
Financial Announcements 43
Aug 14, 2018: Cancer Genetics announces second quarter 2018 financial results 43
May 15, 2018: Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates 45
Apr 02, 2018: Cancer Genetics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Strategic Business Updates 47
Nov 09, 2017: Cancer Genetics Reports Record Third Quarter 2017 Revenue and 134% Increase in Contracted Bookings from Major Biotech and Pharmaceutical Companies 49
Aug 14, 2017: Cancer Genetics Announces Second Quarter 2017 Financial Results, Accretive Acquisition and Capital Raise 51
May 11, 2017: Cancer Genetics Announces 15% Revenue Increase in First Quarter of 2017 over 2016 on Strong Organic Growth While Continuing on Path to Profitability 53
Mar 23, 2017: Cancer Genetics Announces Record Revenue for Fourth Quarter and Full-Year 2016 and Provides 2017 Business Update 55
Corporate Communications 57
Jun 12, 2018: Cancer Genetics Appoints Michael McCartney As Chief Commercial Officer 57
Feb 05, 2018: Cancer Genetics Announces Resignation Of Panna Sharma As Chief Executive Officer 58
Nov 27, 2017: Cancer Genetics Appoints Renowned Biotech Entrepreneur Dr. Thomas F. Widmann to its Board of Directors 59
Feb 22, 2017: Cancer Genetics to Receive $1.0 Million in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program 60
Legal and Regulatory 61
May 06, 2018: Kaskela Law: Shareholder Class Action Filed Against Cancer Genetics 61
Product News 62
Sep 20, 2018: Cancer Genetics offers Oncomine comprehensive assay to drive clinical trials 62
Dec 11, 2017: Cancer Genetics Advances Understanding of Immune Response and Measurement in Lymphomas by Combining PD-L1 Expression Analysis With RNA Analysis 63
Oct 30, 2017: Cancer Genetics a Leader in Personalized Medicine – Launches AntigenID, Solidifying CGI’s Position as a Precision Oncology Leader in the Fast Growing, Rapidly-Evolving Field of Immuno-Oncology Therapy & Drug Development 64
Oct 12, 2017: Cancer Genetics to Host Panel Discussion on “The Convergence of Artificial Intelligence and Healthcare – New Developments in Precision Medicine” 65
Sep 20, 2017: Cancer Genetics Announces 25th Contract Win to Provide Testing & Diagnostic Services for Combination Immuno-Oncology Clinical Trial 66
Jun 02, 2017: Cancer Genetics to Present at the 7th Annual LD Micro Invitational 67
Mar 13, 2017: Cancer Genetics to Present at “A Future Without Cancer Conference” on Friday, March 17 68
Other Significant Developments 69
Oct 08, 2018: Cancer Genetics and Cellaria partner on precision medicine tools 69
Nov 29, 2017: Cancer Genetics Initiates Partnership to Reduce Alarmingly Increasing Cancer Mortality Rates in India 70
Apr 10, 2017: Cancer Genetics is Selected by eFFECTOR Therapeutics to Provide Biomarker Discovery and Development Services for Novel Oncology Drugs 71
Jan 06, 2017: Cancer Genetics Announces Consolidation and Cost Reduction in Administrative and Operational Support Functions 72
Appendix 73
Methodology 73
About GlobalData 73
Contact Us 73
Disclaimer 73
Cancer Genetics Inc, Medical Equipment, Key Facts, 2017 2
Cancer Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cancer Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Cancer Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Cancer Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Cancer Genetics Inc, Deals By Market, 2012 to YTD 2018 9
Cancer Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Cancer Genetics Acquires Assets of Response Genetics for USD14 Million 11
PierianDx Enters into Agreement with Cancer Genetics 13
Cancer Genetics Enters into Partnership with Mendel Health 14
Cancer Genetics Enters into Agreement with Lantern Pharma 15
Cancer Genetics Partners with ApoCell for ApoStream 16
Cancer Genetics Partners with H3 Biomedicine 17
Cancer Genetics Enters into Distribution Agreement with Sayre Therapeutics 18
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 19
Cancer Genetics Italia Enters Into Distribution Agreement With Nikon Instruments 20
NovellusDx to Merge with Cancer Genetics 21
Cancer Genetics Prices USD7 Million in Private Placement of Units 23
Cancer Genetics Raises USD3 Million in First Tranche of Private Placement of Shares 24
Cancer Genetics to Raise USD5.5 Million in Private Placement of Shares and Warrants 25
Cancer Genetics Raises USD5 Million in Private Placement of Shares and Warrants 26
Cancer Genetics Raises USD12 Million in Public Offering of Shares 27
Cancer Genetics Completes Public Offering Of Shares For US$46 Million 29
Cancer Genetic Announces Public Offering Of Common Stock For Up To US$50 Million 31
Cancer Genetics Completes Underwriters' Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For US$16 Million 32
Cancer Genetics Completes IPO For US$7 Million 33
Cancer Genetics Raises USD2.6 Million in Private Placement of 10% Notes Due 2019 35
ReproCELL Acquires BioServe Biotech from Cancer Genetics for USD1.9 Million 36
Cancer Genetics Inc, Key Competitors 37
Cancer Genetics Inc, Key Employees 38
Cancer Genetics Inc, Other Locations 39
Cancer Genetics Inc, Subsidiaries 39
Cancer Genetics Inc, Joint Venture 40
List of Figures
Cancer Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cancer Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cancer Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cancer Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cancer Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Cancer Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Cancer Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Cancer Genetics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9